Cardiologist discusses COVID-19, myocarditis among professional athletes and more

A cardiologist who works closely with professional athletes has shared his perspective on the ongoing pandemic, myocarditis, safety protocols and more.

Matthew W. Martinez, MD, works for Atlantic Health System Sports Cardiology at Morristown Medical Center in New Jersey. He was already consulting the NBA Players Association before COVID-19, but his role with the league clearly grew more important than ever once the pandemic hit the United States.

In a new interview with Sports Illustrated, Martinez detailed some of the latest and greatest data on COVID-related heart damage among professional athletes. One of the biggest takeaways from that interview is that cardiac complications appear to be rare among athletes diagnosed with COVID-19.

“Initially, our concern was based primarily on hospitalized, sicker patients with COVID-19, and we were concerned about its effect on the athlete heart, given the potential for myocarditis—or damage to the heart muscle—being a cause of sudden death in athletes,” he said. “And what we now know is that the prevalence of cardiac involvement among athletes, specifically professional athletes and specifically the NBA players, is unusual.”

Martinez also reviewed the various safety protocols he has helped develop since the pandemic began, noting that he and his colleagues are working around the clock to examine these athletes and ensure they are as safe as possible.

“I’ve spoken with more athletes who’ve had viral illness in the last six months to a year than I had in the previous decade,” he said. “So to say that we’re being diligent in this group would be the understatement of the [year].”

Martinez also noted that he will soon be submitting some key findings to JAMA Cardiology.

The interview is full of fascinating information—click the link below to read the full thing:

 

Related COVID-19 Content:

Myocarditis, arrhythmias and more: An ACC update on what cardiologists know about long COVID-19

Athletes with COVID-19 may require heart MRI screening for myocarditis, new data suggest

4 cardiac arrhythmias associated with COVID-19

What we know about COVID-19 and cardiogenic shock

Mild COVID-19 infections not associated with long-term risk of heart damage

The pandemic’s toll: 55 long-term side effects of COVID-19

4 key takeaways from an updated look at vaccine-related myocarditis in the U.S.

Most young people with vaccine-related myocarditis recover quickly

Intrathoracic complications in COVID patients: Incidence, associations and outcomes

Congenital heart disease increases risk of poor COVID-19 outcomes, including death

MRI scans show COVID's 'significant' impact on the brain

Heart complication seen for the first time in a young patient after COVID-19 vaccination

American Heart Association investing $10 million to study the long-term consequences of COVID-19

Cardiologist discusses COVID-19, myocarditis among professional athletes and more

Not so fast: Specialists warn against cardiac imaging for asymptomatic COVID-19 patients

Study shows COVID-19 can infect heart cells—and do serious damage in the process

ACC issues COVID-19 guidance for cardiologists

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.